Cambridge, UK, 02 March 2021: CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip, today announced it has received a grant from Innovate UK, the UK’s innovation agency, to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection. The funding will be used to develop and test advanced cell culture models that represent different regions of the lung and subsequently linking these models to other organ systems, such as liver and gut, to inform the rapid development of novel therapeutics.
The fast-moving…
Bruntwood SciTech, the UK’s leading property provider dedicated to the growth of the science and technology sector, has acquired a long leasehold over Melbourn Science Park from TTP for £46.2m and will work closely with the local planning authority in the coming months to develop a new ambitious masterplan for the 16.4 acre site; creating a long term vision for the future growth of the science park as a leading science and technology cluster in Cambridge.
The new strategic partnership will see Bruntwood SciTech and TTP, which has many years of experience of working in life sciences,…
SOMERSET, N.J. and GOSSELIES, BELGIUM – February 23, 2021 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics. Catalent is also announcing the launch of pDNA…
PLG is very excited to announce the re-start of our monthly newsletter, to keep everyone up to date with our activities and news.
Please see link:
https://productlifegroup.com/blog/february-newsletter/
Cambridge, UK, 23rd February 2021: Chesterford Research Park is delighted to confirm the expansion of Camena Bioscience within the Science Village Building at the Park. The developer of an industry-leading DNA synthesis technology has renewed its existing lease for a further five years and in tandem taken an additional 1,993 sq ft adjoining suite on the same terms.Founded in 2016, Camena Bioscience has been based at Chesterford Research Park since its incorporation. The company’s multi-enzymatic technology, called gSynth™, has dramatically improved the accuracy of DNA synthesis…
Ahead of the Chancellor’s Budget on 3rd March 2021, Cambridge Tax Partner Hannah Simoes and Deloitte experts give their key predictions for the event. The UK’s regions continue as an expected area of focus in this Budget.
Economic outlook
Ian Stewart, chief economist, said:
“The focus of this Budget should be on growth. The heavy lifting needed to rebuild the public finances will need to wait until the recovery is well entrenched. This Budget is likely to outline a road map for the winding down of pandemic support schemes along with more limited and selective support for at risk sectors.…
Stevenage Bioscience Catalyst (SBC) has launched a free accelerator programme to give data-focussed biotech start-ups the skills they need to get potential new drugs and therapiesto market more quickly.The programme will run from May and is aimed at supporting start-up companies working to discover new drugs. Those selected will take part in an 18-week programme during which they will have the opportunity to network and learn from experts in the pharmaceutical and biotech industries. Start-ups will be able to build their expertise in structuring deals, accessing data,…
A first of its kind virtual platform - ‘UK Healthcare Pavilion’ - that showcases the very best of UK healthcare and life sciences, has been launched.
The site provides news, insights, and interviews from a variety of key opinion leaders and policy makers, offering their views on topical subjects in the sector and showcasing the strengths the UK has to offer.
The platform will support UK companies to increase export opportunities, as alongside this is a searchable directory of UK companies providing overseas buyers with a simple and intuitive way to identify and engage with UK industry…
A team of Discovery Park scientists researching human neurological and psychiatric health conditions is expanding research opportunities for its Kent-based team in mainland Europe, by opening an additional laboratory in Poland.
The Transpharmation team only announced the move of its headquarters and main laboratory to Discovery Park itself in November 2020, and started working from its laboratories there this month (February 2021). The additional Poland expansion means newly-recruited scientists, students and research assistants at Discovery Park will be able to forge new relationships with…